K. Chiba
Impact in
- Neurology top 10%
- Vestibular and auditory disorders
Papers in
-
- Immune Response and Inflammation 4
- Toxin Mechanisms and Immunotoxins 2
-
- Natural product bioactivities and synthesis 2
- Co-authors
- Hideo Tohgi (4 shared papers)Kaoru Tohyama (1 shared paper)Keisuke Kawakami (1 shared paper)Yoshiyuki Hirata (1 shared paper)Shin Takahashi (1 shared paper)Takahiro Mori (1 shared paper)Hideyuki Yoshida (1 shared paper)Y. Toyama (1 shared paper)
- Journals
- Inflammation Research (5 papers)Stroke (3 papers)European Journal of Medicinal Chemistry (2 papers)Toxicology in Vitro (2 papers)Neuroradiology (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
K. Chiba
18 papers receiving 735 citations
Peers
Comparison fields: 5 of 111
- Neurology 79
- Neurology 113
- Immunology 110
- Rheumatology 76
- Pharmacology 35
Countries citing papers authored by K. Chiba
This map shows the geographic impact of K. Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Chiba more than expected).
Fields of papers citing papers by K. Chiba
This network shows the impact of papers produced by K. Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Chiba. The network helps show where K. Chiba may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Chiba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 272 | |
| 2 | 1998 | 160 | |
| 3 | 1993 | 134 | |
| 4 | 1991 | 87 | |
| 5 | 1993 | 30 | |
| 6 | 1998 | 24 | |
| 7 | 1999 | 10 | |
| 8 | 1988 | 9 | |
| 9 | 1999 | 9 | |
| 10 | 1987 | 5 | |
| 11 | 1991 | 5 | |
| 12 | 1995 | 4 | |
| 13 | 1991 | 3 | |
| 14 | 1991 | 3 | |
| 15 | 1991 | 3 | |
| 16 | Purification and lyophylization of Weil's disease therapeutic serum. | 1973 | 2 |
| 17 | 1989 | 1 | |
| 18 | 1996 | 1 | |
| 19 | 2024 | 0 | |
| 20 | 2023 | 0 |
About K. Chiba
K. Chiba is a scholar working on Immunology, Molecular Biology, Pharmacology, Organic Chemistry and Small Animals, having authored 20 papers that have together received 762 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (4 papers), Immune Response and Inflammation (4 papers), Natural product bioactivities and synthesis (2 papers), Animal testing and alternatives (2 papers), Synthesis and biological activity (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Acute Ischemic Stroke Management (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Neurology (79 citations), Neurology (113 citations), Immunology (110 citations), Rheumatology (76 citations) and Pharmacology (35 citations). K. Chiba has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hideo Tohgi, Kaoru Tohyama, Keisuke Kawakami, Yoshiyuki Hirata, Shin Takahashi, Takahiro Mori, Hideyuki Yoshida, Y. Toyama, Hideo Morioka and Akihiko Yoshimura. Their work appears in journals such as Inflammation Research, Stroke, European Journal of Medicinal Chemistry, Toxicology in Vitro and Neuroradiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.